Indicators

Latest News about WST

Recent news which mentions WST

< Previous 1 2 3 4 5 6 7 Next >

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization

September 09, 2021

7 Top-Performing S&P 500 Stocks to Watch

September 08, 2021

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself

September 03, 2021

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering

September 01, 2021

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

August 31, 2021

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

August 24, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

Stocks That Hit 52-Week Highs On Thursday

August 19, 2021

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

August 19, 2021

Stocks That Hit 52-Week Highs On Wednesday

August 18, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

Stocks That Hit 52-Week Highs On Monday

August 16, 2021

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

August 11, 2021

Stocks That Hit 52-Week Highs On Tuesday

August 10, 2021

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO

August 06, 2021

Stocks That Hit 52-Week Highs On Wednesday

August 04, 2021

Stocks That Hit 52-Week Highs On Tuesday

August 03, 2021

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business

August 03, 2021

Stocks That Hit 52-Week Highs On Friday

July 30, 2021

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs

July 30, 2021

10 Biggest Price Target Changes For Friday

July 30, 2021

West Pharmaceutical Services (WST) Q2 2021 Earnings Call Transcript

July 29, 2021

Stocks That Hit 52-Week Highs On Thursday

July 29, 2021

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs

July 29, 2021

Recap: West Pharmaceutical Services Q2 Earnings

July 29, 2021

Earnings Scheduled For July 29, 2021

July 29, 2021

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More

July 25, 2021

Stocks That Hit 52-Week Highs On Friday

July 23, 2021

Ex-Dividend Date Insight: West Pharmaceutical Servs

July 19, 2021

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.